Brafo SRL
The score of Brafo shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +219 % Total assets +121 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Brafo's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 14 Jul 2026
- Year ended 31 Dec 2024filed on 10 Jul 2025
- Year ended 31 Dec 2023filed on 15 Jul 2024
- Year ended 31 Dec 2022filed on 11 Jul 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
Brafo's financial analysis
- Solvency52.3%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Brafo
Brafo's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0598.967.377
- VAT number
- BE0598967377
- Peppol
- Registered · 0208:0598967377 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Feb 2015
- Registered office
- 8200 Bruges
- Latest accounts
- 2025 · filed on 14 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Brafo (SRL) has been based in Bruges since 2015, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 367,269 € and equity of €1.83m; its revenue is not published. Its solvency stands at 52.3%, above the median of its sector (44.0%).
Companies similar to Brafo
Companies in the same business, of comparable size and area, outside its group.
- Filepharma Invest Activities of head offices Soignies · balance sheet €1.10m
- Ardal Pharma Business and other management consultancy activities Jette · balance sheet €1.22m
- Pharmacie DE Thisnes Retail sale of pharmaceutical products Hannut · balance sheet €2.10m
- DAHO Retail sale of pharmaceutical products Scherpenheuvel-Zichem · balance sheet €7.91m
- RED ONE Pharma Retail sale of pharmaceutical products Brussels · balance sheet €1.19m
- K & K Management Retail sale of pharmaceutical products Mol · balance sheet €2.36m
- Dehouck Retail sale of pharmaceutical products Ostend · balance sheet €3.76m
- Cathy Bernard Management Retail sale of pharmaceutical products Soumagne · balance sheet €3.03m
Frequently asked questions about Brafo
What is the revenue of Brafo?
Brafo files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Brafo?
In Belgium, the VAT number is the company number prefixed with BE: BE0598967377 for Brafo, if the company is VAT-registered. Its company number (CBE) is 0598.967.377.
Where is the registered office of Brafo?
According to the CBE register, the registered office of Brafo is in 8200 Bruges.
What is the equity of Brafo?
At the close of the 2025 financial year, the equity of Brafo amounts to 1,825,527 €, a solvency of 52.3% of total assets.
Who manages Brafo?
The register lists 2 active mandates at Brafo. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Brafo
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →